We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Stem Cell Therapeutics Announces Issuance of Patents in India
News

Stem Cell Therapeutics Announces Issuance of Patents in India

Stem Cell Therapeutics Announces Issuance of Patents in India
News

Stem Cell Therapeutics Announces Issuance of Patents in India

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Stem Cell Therapeutics Announces Issuance of Patents in India"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Stem Cell Therapeutics Corp. has been issued two patents in India: Indian Patent No. 229684 entitled, "Combined Regulation of Neural Cell Production" and Indian Patent No. 229924 entitled, "A Composition for Increasing Neural Stem Cell Number and In Vitro Method of Using the Same".

Together, these patents cover pharmaceutical compositions for increasing neural stem cell number or for producing specialized neural stem cell progeny, with the compositions comprising prolactin in combination with other neural stem cell proliferating agents or differentiating agents, such as erythropoietin ("EPO").

Methods for using prolactin and other such agents in neural stem cell culture are also covered, with the resulting cells being useful, for example, in regenerative transplant therapy.

Dr. Alan Moore, President and CEO, commented as follows: "Overall, India is playing a valuable role in our development programs. It is therefore increasingly important to address intellectual property issues in India. These two patents are part of that process."
Advertisement